Search

Your search keyword '"Phosphodiesterase-4"' showing total 339 results

Search Constraints

Start Over You searched for: Descriptor "Phosphodiesterase-4" Remove constraint Descriptor: "Phosphodiesterase-4"
339 results on '"Phosphodiesterase-4"'

Search Results

301. The PDE4 inhibitor CHF-6001 and LAMAs inhibit bronchoconstriction-induced remodeling in lung slices.

302. The discovery, complex crystal structure, and recognition mechanism of a novel natural PDE4 inhibitor from Selaginella pulvinata.

303. Overexpression of phosphodiesterase-4 subtypes involved in surgery-induced neuroinflammation and cognitive dysfunction in mice.

304. FFPM, a PDE4 inhibitor, reverses learning and memory deficits in APP/PS1 transgenic mice via cAMP/PKA/CREB signaling and anti-inflammatory effects.

305. Phosphodiesterase-4B as a Therapeutic Target for Cognitive Impairment and Obesity-Related Metabolic Diseases.

306. Phosphodiesterase 4 Inhibitors

308. Inhibition of phosphodiesterase 4 in allergic rhinitis

309. Review: Oral phosphodiesterase 4 inhibitors reduce exacerbations but increase adverse events in COPD

311. Phosphodiesterase Inhibitor Attenuation of Fibroblast Chemotaxis Depends on Endogenous Prostaglandin Production

312. Changes of brain phosphodiesterase 4 in major depression

313. S1593 S-Adenosylmethionine (SAM) Down-Regulates LPS-Inducible Phosphodiesterase 4 Activity, Increases cAMP Levels and Decreases TNFα Expression in Monocytes: Relevance to Alcoholic Liver Disease

314. Phosphodiesterase-4 Inhibition and Brain Tumor Growth

315. GLUCOCORTICOSTEROIDS PREVENT THE PRO-ASTHMATIC EFFECTS OF PROLONGED EXPOSURE TO A LONG-ACTING BETA2-ADRENOCEPTOR AGONIST IN AIRWAY SMOOTH MUSCLE (ASM) BY MODULATING PHOSPHODIESTERASE 4 (PDE4) ACTIVITY

317. 083 Effect of Phosphodiesterase-4 Inhibition on Development of Monocrotaline – and Hypoxia – Induced Pulmonary Hypertension in Rats

318. Corrigendum to 'Quantification of brain phosphodiesterase 4 in rat with (R)-[11C]rolipram-PET' [NeuroImage 26 (2005) 1201–1210]

321. Quantification of brain phosphodiesterase 4 in rats using [11C]rolipram PET after antidepressant treatment

322. New targets in psoriatic arthritis.

323. Inhibition of Uterine Contractility by Thalidomide Analogs via Phosphodiesterase-4 Inhibition and Calcium Entry Blockade.

324. Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study design.

325. Inhibition of phosphodiesterase-4 reverses the cognitive dysfunction and oxidative stress induced by Aβ25-35 in rats.

326. Inhibition of Phosphodiesterase-4 during Pneumococcal Pneumonia Reduces Inflammation and Lung Injury in Mice.

327. Discovery and modelling studies of natural ingredients from Gaultheria yunnanensis (FRANCH.) against phosphodiesterase-4.

328. Phosphodiesterase-4 inhibition as a therapeutic strategy for metabolic disorders.

332. Decrease of phosphorylated CREB and ERK in nucleus accumbens is associated with the incubation of heroin seeking induced by cues after withdrawal.

334. Therapeutic development in psoriasis.

335. The molecular basis for the inhibition of phosphodiesterase-4D by three natural resveratrol analogs. Isolation, molecular docking, molecular dynamics simulations, binding free energy, and bioassay.

336. Methylxanthines do not affect rhythmogenic preBötC inspiratory network activity but impair bursting of preBötC-driven motoneurons.

337. Crystal structure of phosphodiesterase 4D and inhibitor complex11Atomic coordinates (code 1MKD) have been deposited in the Protein Data Bank

338. Phosphodiesterase 4-targeted treatments for autoimmune diseases

339. Restoring persistent accessibility to memories after sleep deprivation-induced amnesia

Catalog

Books, media, physical & digital resources